Sunday, February 01, 2015
Add My Company Services
Clinical Trials (Phase I, II, III & IV) (13)
Contract Sales & Marketing (3)
Data Management (6)
Logistics, Supply Chain (6)
Project Management (2)
Quality Assurance/Quality Control (11)
Contract Research / Contract Manufacturing
Biologics/ Biosimilars (6)
Bulk Ingredients / Chemical Production (1)
Compound Libraries (3)
Engineering Resources (1)
Fill & Finish, Packaging (13)
In-silico Drug Discovery (2)
Medicinal Chemistry (3)
Screening/Assay Development (9)
Target Discovery (3)
Drug Design & Delivery (10)
NIH Launches Tool to Advance Down Syndrome Research
Web portal will help approved professionals to plan clinical studies.
NIH Researchers Tackle Thorny Side of Gene Therapy
Pre-clinical studies in mice reveal ways to reduce cancer risk with modified treatment.
Early Blood Glucose Control Lengthens Life in People with Type 1 Diabetes
Reductions in diabetes complications resulting from tight glucose control translate into longer lifespans.
Oxford Vaccine Group Begins First Trial of New Ebola Vaccine
Oxford University doctors and scientists are starting the first safety trial of an experimental preventative Ebola vaccine regimen being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen).
GRP78 Protein Possible Universal Therapeutic Target
Drug combination including Viagra is effective tool in targeting the protein.
Stem Cell Transplants May Halt Progression of Multiple Sclerosis
NIH-funded study yields encouraging early results.
Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes
Promising profile of disease modification and pain reduction leads to proof of concept trials.
Parkinson's Vaccine: EU-Team Launches Clinical Trial
Vaccine candidate based on proprietary technology by AFFiRiS AG.
Two Drugs are No More Effective Than One to Treat Common Kidney Disease
NIH study finds limited kidney benefit from more rigorous blood pressure treatment.
Gene Therapy Provides Safe, Long-Term Relief for Patients with Severe Hemophilia B
Gene therapy pioneered by St. Jude Children’s Research Hospital, University College London and the Royal Free Hospital provides men with hemophilia B reliable relief from the bleeding disorder.
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.